Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
Karin PM van Galen(University Medical Center Utrecht), Roger E. G. Schutgens(University Medical Center Utrecht), Evelien P. Mauser‐Bunschoten(University Medical Center Utrecht), Eveline T Engelen(University Medical Center Utrecht), Robert JJ van Es(Heidelberg University)
Cited by 82
Related Papers
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
|Blood|2017|300
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
|Haemophilia|2011|244
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
|The Lancet Haematology|2021|237